Takuto Maeda
Overview
Explore the profile of Takuto Maeda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
147
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanaka M, Moniwa N, Nogi C, Kano T, Matsumoto M, Sakai A, et al.
J Nephrol
. 2023 Jan;
36(2):385-395.
PMID: 36622635
Background: Fatty acid-binding protein 4 (FABP4) is secreted from adipocytes and macrophages in adipose tissue and acts as an adipokine. It has recently been reported that FABP4, but not liver-type...
2.
Abe K, Shimamura Y, Nishizawa K, Maeda T, Yane K, Shinohara T, et al.
Nefrologia (Engl Ed)
. 2022 Sep;
41(3):352-354.
PMID: 36165342
No abstract available.
3.
Miki K, Shimamura Y, Maeda T, Moniwa N, Ogawa Y, Shimizu T, et al.
CEN Case Rep
. 2022 Jul;
12(1):56-62.
PMID: 35854043
Crystalline light chain cast nephropathy is a rare distinct morphologic variant of light chain cast nephropathy which is the most common renal lesion associated with multiple myeloma. It is often...
4.
Gocho Y, Tanaka M, Sugawara H, Furuhashi M, Moniwa N, Yamashita T, et al.
Clin Exp Nephrol
. 2021 Jul;
25(12):1360-1366.
PMID: 34251521
Background: Serum vitamin D level shows a seasonal variation, being lower in winter than in summer in healthy subjects. The aim of this study was to determine whether there is...
5.
Shimamura Y, Abe K, Maeda T, Ogawa Y, Takizawa H, Ishigami J, et al.
Medicine (Baltimore)
. 2021 May;
100(18):e25845.
PMID: 33950999
We examined the association between diuretic administration before the diagnosis of minimal change disease and the incidence of acute kidney injury. Moreover, we examined whether the use of diuretics affected...
6.
Shimamura Y, Abe K, Maeda T, Matsui T, Ishiguro A, Takizawa H
In Vivo
. 2021 Apr;
35(3):1647-1653.
PMID: 33910848
Background/aim: Lenvatinib, a multitargeted tyrosine kinase inhibitor, was recently approved for hepatocellular carcinoma (HCC) treatment in Japan; however, the association between proteinuria following lenvatinib administration in HCC patients and early...
7.
Shimamura Y, Maeda T, Abe K, Ogawa Y, Takizawa H
CEN Case Rep
. 2021 Feb;
10(3):435-441.
PMID: 33616883
Selective immunoglobulin M deficiency (SIgMD) is the isolated absence of serum immunoglobulin M (IgM) with normal levels of other serum immunoglobulins. SIgMD is associated with infections and autoimmune diseases. While...
8.
Abe K, Shimamura Y, Maeda T, Kato Y, Yoshimura Y, Tanaka T, et al.
Ren Replace Ther
. 2021 Jan;
6(1):36.
PMID: 33510901
Background: Social frailty-the lack of a connection to society and infrequent social activities-has been reported to be associated with future declines in physical function in elderly individuals. This study aimed...
9.
Shimamura Y, Watanabe S, Maeda T, Abe K, Ogawa Y, Takizawa H
Clin Exp Nephrol
. 2021 Jan;
25(5):479-487.
PMID: 33471239
Background: Immune checkpoint inhibitors (ICPis) are associated with multi-organ immune-related adverse effects. Here, we examined the incidence rate, recovery rate, and risk factors of acute kidney injury complicated with ICPis...
10.
Tanaka M, Furuhashi M, Moniwa N, Maeda T, Takizawa H, Matsumoto M, et al.
BMC Nephrol
. 2020 Nov;
21(1):459.
PMID: 33143633
Background: Fatty acid-binding protein 4 (FABP4), but not FABP1 (liver-type FABP), is ectopically induced in injured glomerular endothelial cells, and urinary FABP4 (U-FABP4) level is associated with proteinuria and renal...